AAAAAA

   
Results: 1-9 |
Results: 9
Correspondence re: C. F. M. Sier et al., enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: A comparison with clinically used tumor markers. Clin. Cancer Res., 6 : 2333-2340, 2000. Reply
Authors: Sier, CFM Verheijen, JH van Lent, N Hanemaaijer, R
Citation: Cfm. Sier et al., Correspondence re: C. F. M. Sier et al., enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: A comparison with clinically used tumor markers. Clin. Cancer Res., 6 : 2333-2340, 2000. Reply, CLIN CANC R, 7(2), 2001, pp. 447-447
PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinasereceptor
Authors: Degryse, B Sier, CFM Resnati, M Conese, M Blasi, F
Citation: B. Degryse et al., PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinasereceptor, FEBS LETTER, 505(2), 2001, pp. 249-254
Plasminogen activators in multiple sclerosis lesions - Implications for the inflammatory response and axonal damage
Authors: Gveric, D Hanemaaijer, R Newcombe, J van Lent, NA Sier, CFM Cuzner, ML
Citation: D. Gveric et al., Plasminogen activators in multiple sclerosis lesions - Implications for the inflammatory response and axonal damage, BRAIN, 124, 2001, pp. 1978-1988
Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices
Authors: Koolwijk, P Sidenius, N Peters, E Sier, CFM Hanemaaijer, R Blasi, F van Hinsbergh, VWM
Citation: P. Koolwijk et al., Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices, BLOOD, 97(10), 2001, pp. 3123-3131
Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9)are associated with early-stage bladder carcinoma: A comparison with clinically used tumor markers
Authors: Sier, CFM Casetta, G Verheijen, JH Tizzani, A Agape, V Kos, J Blasi, F Hanemaaijer, R
Citation: Cfm. Sier et al., Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9)are associated with early-stage bladder carcinoma: A comparison with clinically used tumor markers, CLIN CANC R, 6(6), 2000, pp. 2333-2340
Shedding and cleavage of the urokinase receptor (uPAR): identification andcharacterisation of uPAR fragments in vitro and in vivo
Authors: Sidenius, N Sier, CFM Blasi, F
Citation: N. Sidenius et al., Shedding and cleavage of the urokinase receptor (uPAR): identification andcharacterisation of uPAR fragments in vitro and in vivo, FEBS LETTER, 475(1), 2000, pp. 52-56
Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy
Authors: Mustjoki, S Sidenius, N Sier, CFM Blasi, F Elonen, E Alitalo, R Vaheri, A
Citation: S. Mustjoki et al., Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy, CANCER RES, 60(24), 2000, pp. 7126-7132
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection
Authors: Sidenius, N Sier, CFM Ullum, H Pedersen, BK Lepri, AC Blasi, F Eugen-Olsen, J
Citation: N. Sidenius et al., Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection, BLOOD, 96(13), 2000, pp. 4091-4095
Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance
Authors: Sier, CFM Sidenius, N Mariani, A Aletti, G Agape, V Ferrari, A Casetta, G Stephens, RW Brunner, N Blasi, F
Citation: Cfm. Sier et al., Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance, LAB INV, 79(6), 1999, pp. 717-722
Risultati: 1-9 |